China-US Precisiong Medicine Industry and Policy ForumOn Monday, June 13th, Dr. A. Mark Fendrick, Director of the Center for Value-Based Insurance Design (V-BID), spoke at the China-US Precision Medicine Industry and Policy Forum.  The Forum is part of a larger event, titled “The Fourth Shenzhen International Low Carbon City Forum,” and took place in Shenzhen, Guangdong Province, China.  Dr. Fendrick also participated in an additional roundtable event held on Sunday, June 12th.

The event will bring together health economists and policy stakeholders to discuss the opportunities and challenges of using genomic science to improve the quality and efficiency of health care and public health services delivery in China and internationally.  Dr. Fendrick will discuss V-BID in the context of the Chinese health system and precision medicine.

Dr. Fendrick’s presentation, including the Chinese translation, can be found below.

China-US Presentation

 

Dr. Fendrick presenting about the key tenets of                   V-BID strategy in China.

AMF3

Dr. Fendrick presenting Dr. Jian Wang, CEO of  Beijing Genomics Institute, with a V-BID t-shirt.

 

 

 

 

 

 

 

 

Dr. Jian Wang

     Dr. Jian Wang, CEO of Beijing Genomics               Institute, presenting in his V-BID t-shirt.

Dr. Fendrick and Mayor Jie Tang of Shenzhen

       Dr. Fendrick and Vice Mayor Jie Tang                                    of Shenzhen.